Summary

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:12-18. doi: 10.1016/j.pnpbp.2017.02.016. Epub 2017 Feb 24.

Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.

Abstract:

PURPOSE: Neural cell adhesion molecule (NCAM) plays an important role in neural plasticity, and its altered function has been implicated in psychiatric disorders. However, previous studies have yielded inconsistent results on cerebrospinal fluid (CSF) NCAM levels in psychiatric disorders. The aim of our study was to examine CSF NCAM levels in patients with schizophrenia, bipolar disorder (BD), and major depressive disorder (MDD), and their possible relationship with clinical variables.
METHODS: The participants comprised 85 patients with schizophrenia, 57 patients with BD, 83 patients with MDD and 111 healthy controls, all matched for age, sex, and Japanese ethnicity. The CSF samples were drawn using a lumbar puncture and NCAM levels were quantified by an enzyme-linked immunosorbent assay.
RESULTS: Analysis of covariance controlling for age and sex revealed that CSF NCAM levels were lower in all patients (p=0.033), and in those with BD (p=0.039), than in the controls. NCAM levels positively correlated with age in patients with BD (p<0.01), MDD (p<0.01), and the controls (p<0.01). NCAM levels negatively correlated with depressive symptom scores in patients with BD (p=0.040). In patients with schizophrenia, NCAM levels correlated negatively with negative symptom scores (p=0.029), and correlated positively with scores for cognitive functions such as category fluency (p=0.011) and letter fluency (p=0.023) scores.
CONCLUSION: We showed that CSF NCAM levels were lower in psychiatric patients, particularly bipolar patients than in the controls. Furthermore, we found correlations of NCAM levels with clinical symptoms in patients with BD and in those with schizophrenia, suggesting the involvement of central NCAM in the symptom formation of severe psychiatric disorders.

日本語要旨:

統合失調症患者85名、双極性障害患者57名、大うつ病性障害患者83名、および健常対照者111名を対象にELISA法で脳脊髄液中NCAMを定量した。NCAM量は精神疾患患者全体で健常対照者と比べ有意に低下し、特に双極性障害患者で有意に低下していた。また、NCAM量は双極性障害群で抑うつ症状と有意な負の相関を示し、統合失調症群では陰性症状と有意に負に、言語流暢性と有意に正に相関していた。本研究により重篤な精神疾患への中枢神経系NCAMの関与が示唆された。

PMID:  28238731

前ページへ戻る

PAGE TOP